[4] As a result, GLP-1 agonists are contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2), a genetic disorder that increases the risk of certain types of tumors
weight gain DPP-4 inhibitors (sitagliptin, linagliptin): Incretin-based
Schaffer A, Verdoia M, Cassetti E, et al
Saxenda (liraglutide) Saxenda contains the substance liraglutide, which is also a GLP-1 receptor agonist, similar to Wegovy and Ozempic
Minimizing injection site reactions Some people experience redness, swelling, or itching at the injection site
They are involved in gene expression, regeneration, cell aging regulation, and cell death